Product Center
Ab&B Bio and Yither Bio have both obtained qualification certification!
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-12-30
- Views:
(Summary description)Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively.
Ab&B Bio and Yither Bio have both obtained qualification certification!
(Summary description)Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-12-30 11:32
- Views:
Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively.
Specialized, refined, unique, and innovative small and medium-sized enterprises refer to those that focus on segmented markets, have outstanding innovation capabilities, high market share, and great development potential. The acquisition of this title represents the authoritative recognition of the enterprise in specialization, refinement, specialization, novelty, and other aspects. Ab&B Bio will also adhere to innovation driven approach, making products more specialized, quality more refined, and brand stronger, so that China can use global innovative vaccines and the world can use high-quality Chinese vaccines.
The recognition of national high-tech enterprises is one of the most authoritative evaluations of a company's comprehensive strength in the field of scientific and technological innovation. This recognition is a comprehensive assessment of the research and development management level, quantity and quality of independent intellectual property rights, ability to transform scientific and technological achievements, growth potential, and talent structure of enterprises by authoritative national departments, reflecting a high recognition of the innovation capability and development potential of enterprises. Yither Bio will continue to enhance its research and development capabilities, accelerate the transformation of scientific and technological achievements, and provide a source of vitality for the company's innovative vaccine development.
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
